FDA panel backs first-of-its-kind flu vaccine using mRNA technology

Associated PressIndependentCenter2 days ago

An FDA panel has approved the first-of-its-kind flu vaccine utilizing mRNA technology.

Bias read (Center): The article reports on an FDA panel's approval of a new type of flu vaccine without presenting any biased language, one-sided sourcing, or editorializing. It focuses on the technological advancement rather than taking a stance on the vaccine's merits or policy implications.